1
|
Eppinger M, Almería S, Allué-Guardia A, Bagi LK, Kalalah AA, Gurtler JB, Fratamico PM. Genome Sequence Analysis and Characterization of Shiga Toxin 2 Production by Escherichia coli O157:H7 Strains Associated With a Laboratory Infection. Front Cell Infect Microbiol 2022; 12:888568. [PMID: 35770066 PMCID: PMC9234449 DOI: 10.3389/fcimb.2022.888568] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Accepted: 05/03/2022] [Indexed: 11/21/2022] Open
Abstract
A laboratory-acquired E. coli O157:H7 infection with associated severe sequelae including hemolytic uremic syndrome occurred in an individual working in the laboratory with a mixture of nalidixic acid-resistant (NalR) O157:H7 mutant strains in a soil-biochar blend. The patient was hospitalized and treated with an intravenous combination of metronidazole and levofloxacin. The present study investigated the source of this severe laboratory acquired infection and further examined the influence of the antibiotics used during treatment on the expression and production of Shiga toxin. Genomes of two Stx2a-and eae-positive O157:H7 strains isolated from the patient's stool were sequenced along with two pairs of the wt strains and their derived NalR mutants used in the laboratory experiments. High-resolution SNP typing determined the strains' individual genetic relatedness and unambiguously identified the two laboratory-derived NalR mutant strains as the source of the researcher's life-threatening disease, rather than a conceivable ingestion of unrelated O157:H7 isolates circulating at the same time. It was further confirmed that in sublethal doses, the antibiotics increased toxin expression and production. Our results support a simultaneous co-infection with clinical strains in the laboratory, which were the causative agents of previous O157:H7 outbreaks, and further that the administration of antibiotics may have impacted the outcome of the infection.
Collapse
Affiliation(s)
- Mark Eppinger
- Department of Molecular Microbiology and Immunology (MMI), University of Texas at San Antonio, San Antonio, TX, United States.,South Texas Center for Emerging Infectious Diseases (STCEID), San Antonio, TX, United States
| | - Sonia Almería
- United States (US) Department of Agriculture (USDA), Agricultural Research Service (ARS), Eastern Regional Research Center, Wyndmoor, PA, United States
| | - Anna Allué-Guardia
- Department of Molecular Microbiology and Immunology (MMI), University of Texas at San Antonio, San Antonio, TX, United States
| | - Lori K Bagi
- United States (US) Department of Agriculture (USDA), Agricultural Research Service (ARS), Eastern Regional Research Center, Wyndmoor, PA, United States
| | - Anwar A Kalalah
- Department of Molecular Microbiology and Immunology (MMI), University of Texas at San Antonio, San Antonio, TX, United States.,South Texas Center for Emerging Infectious Diseases (STCEID), San Antonio, TX, United States
| | - Joshua B Gurtler
- United States (US) Department of Agriculture (USDA), Agricultural Research Service (ARS), Eastern Regional Research Center, Wyndmoor, PA, United States
| | - Pina M Fratamico
- United States (US) Department of Agriculture (USDA), Agricultural Research Service (ARS), Eastern Regional Research Center, Wyndmoor, PA, United States
| |
Collapse
|
2
|
Affiliation(s)
- Betty Kupskay
- Canadian Science Centre for Human and Animal Health (CSCHAH), Winnipeg, Manitoba, Canada
| |
Collapse
|
3
|
Byers KB. Biosafety Tips. APPLIED BIOSAFETY 2009. [DOI: 10.1177/153567600901400108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
4
|
Spina N, Zansky S, Dumas N, Kondracki S. Four laboratory-associated cases of infection with Escherichia coli O157:H7. J Clin Microbiol 2005; 43:2938-9. [PMID: 15956425 PMCID: PMC1151895 DOI: 10.1128/jcm.43.6.2938-2939.2005] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
An investigation of four cases of infection with Escherichia coli O157:H7 among laboratorians from different clinical laboratories revealed that the DNA fingerprint pattern of each case isolate was indistinguishable from that of an isolate handled in the laboratory prior to illness. These data suggest that the infections were laboratory acquired, and they demonstrate the importance of laboratorians strictly adhering to biosafety practices recommended for the handling of infectious materials.
Collapse
Affiliation(s)
- Nancy Spina
- Emerging Infections Program, New York State Department of Health, Room 651 Corning Tower, Empire State Plaza, Albany, NY 12237, USA.
| | | | | | | |
Collapse
|
5
|
Salerno AE, Meyers KEC, McGowan KL, Kaplan BS. Hemolytic uremic syndrome in a child with laboratory-acquired Escherichia coli O157:H7. J Pediatr 2004; 145:412-4. [PMID: 15343202 DOI: 10.1016/j.jpeds.2004.05.040] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
A 6-year-old girl touched an agar plate containing Escherichia coli O157:H7 while visiting a hospital laboratory, and subsequently, colitis and hemolytic uremic syndrome developed. Pulsed-field gel electrophoresis patterns of the isolate cultured from her stool and that from the laboratory were identical.
Collapse
Affiliation(s)
- Ann E Salerno
- Division of Nephrology, Department of Pediatrics, Children's Hospital of Philadelphia, 34th Street & Civic Center Boulevard, Philadelphia, PA 19104, USA
| | | | | | | |
Collapse
|
7
|
Abstract
Infections caused by verocytotoxigenic Escherichia coli O157 (VTEC O157) have emerged as a major public health concern. The nature and severity of associated clinical sequelae are such that symptomatic cases often require hospitalization, with possible exposure to other patients and healthcare workers, including laboratory personnel, to the risk of acquiring VTEC O157. The occurrence of such episodes of hospital- and laboratory-acquired infections has demonstrated that these concerns are justified. Hospital infection control teams must ensure that staff are aware of this potential hazard, and laboratories must review their operating procedures to ensure that their personnel are not unnecessarily exposed, particularly in the light of revised guidance on the safe handling of these organisms.
Collapse
Affiliation(s)
- J E Coia
- Department of Clinical Microbiology, Western General Hospitals NHS Trust, Edinburgh, UK
| |
Collapse
|
8
|
Colombo S, Pacciarini ML, Fusi P. Isolation of a new phenotypic variant of E coli O157:H7 from food. Vet Rec 1998; 142:144-5. [PMID: 9507650 DOI: 10.1136/vr.142.6.144] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- S Colombo
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia, Brescia, Italy
| | | | | |
Collapse
|
9
|
Coia JE. Clinical, microbiological and epidemiological aspects of Escherichia coli O157 infection. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 1998; 20:1-9. [PMID: 9514570 DOI: 10.1111/j.1574-695x.1998.tb01105.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
In the last decade infections caused by Escherichia coli O157:H7 and other verocytotoxigenic E. coli (VTEC) have emerged as a major public health concern in North America and in Europe, and increasingly in other areas of the world. Although absolute numbers of infections are low in comparison with other enteric pathogens such as Salmonella or Campylobacter, it is well-recognised that E. coli O157 can produce severe, potentially life-threatening, illness. As a consequence of this awareness, there has been a rapid expansion of our knowledge about these organisms and the diseases which they cause. In this article, the clinical, microbiological and epidemiological features of VTEC O157 infection are reviewed.
Collapse
Affiliation(s)
- J E Coia
- Department of Clinical Microbiology, Western General Hospitals NHS Trust, Edinburgh, UK.
| |
Collapse
|